69
Views
2
CrossRef citations to date
0
Altmetric
Theme: Alzheimer's disease - Special Report

Management of suspected Alzheimer’s disease patients by specialist physicians at the first visit in Spain: First Consultation Study

&
Pages 657-663 | Published online: 09 Jan 2014

References

  • Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer’s disease. Nat. Med.10(Suppl.), S34–S41 (2004).
  • Borroni B, Di LM, Padovani A. Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful? Eur. J. Pharmacol.545(1), 73–80 (2006).
  • de Pedro-Cuesta J, Virués-Ortega J, Vega S et al. Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990–2008. BMC Neurol.9, 55 (2009).
  • Cacabelos R, Fernandez-Novoa L, Lombardi V, Corzo L, Pichel V, Kubota Y. Cerebrovascular risk factors in Alzheimer’s disease: brain hemodynamics and pharmacogenomic implications. Neurol. Res.25(6), 567–580 (2003).
  • Fillit HM, Doody RS, Binaso K et al. Recommendations for best practices in the treatment of Alzheimer’s disease in managed care. Am. J. Geriatr. Pharmacother.4(Suppl A.), S9–S24; quiz S25–S28 (2006).
  • Sloane PD, Zimmerman S, Suchindran C et al. The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu. Rev. Public Health23, 213–231 (2002).
  • Waldemar G, Dubois B, Emre M et al. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. Eur. J. Neurol.14(1), e1–e26 (2007).
  • Frisoni GB, Padovani A, Wahlund LO. The predementia diagnosis of Alzheimer disease. Alzheimer Dis. Assoc. Disord.18(2), 51–53 (2004).
  • Robillard A. Clinical diagnosis of dementia. Alzheimer Dement.3, 292–298 (2007).
  • Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12(3), 189–198 (1975).
  • Doody RS. Current treatments for Alzheimer’s disease: cholinesterase inhibitors. J. Clin. Psychiatry64(Suppl. 9), 11–17 (2003).
  • Tariot PN. Contemporary issues in the treatment of Alzheimer’s disease: tangible benefits of current therapies. J. Clin. Psychiatry67(Suppl. 3), 15–22 (2006).
  • Cherry DL, Vickrey BG, Schwankovsky L, Heck E, Plauchm M, Yep R. Interventions to improve quality of care: the Kaiser Permanente-Alzheimer’s Association Dementia Care Project. Am. J. Manag. Care10(8), 553–560 (2004).
  • Wilkinson D, Sganga A, Stave C, O’Connell B. Implications of the Facing Dementia Survey for health care professionals across Europe. Int. J. Clin. Pract. Suppl. (146), 27–31 (2005).
  • Bond J, Stave C, Sganga A, O’Connell B, Stanley RL. Inequalities in dementia care across Europe: key findings of the Facing Dementia Survey. Int. J. Clin. Pract. Suppl. (146), 8–14 (2005).
  • Solomon PR, Murphy CA. Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics60(11), 26–31 (2005).
  • McKeith I, Cummings J. Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurol.4(11), 735–742 (2005).
  • Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am. J. Geriatr. Psychiatry11(2), 131–145 (2003).
  • Doody RS, Stevens JC, Beck C et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology56(9), 1154–1166 (2001).
  • Olazaran J, Muniz R, Reisberg B et al. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology63(12), 2348–2353 (2004).
  • Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A. High PIB retention in Alzheimer’s disease is an early event with complex relationship with CSF biomarkers and functional parameters. Curr Alzheimer Res.7(1), 56–66 (2010).
  • Forsberg A, Engler H, Almkvist O et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging29(10), 1456–1465 (2008).
  • van Exel E, Eikelenboom P, Comijs H et al. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease. Arch. Gen. Psychiatry66(11), 1263–1270 (2009).
  • Wenisch E, Cantegreil-Kallen I, De Rotrou J et al. Cognitive stimulation intervention for elders with mild cognitive impairment compared with normal aged subjects: preliminary results. Aging Clin. Exp. Res.19(4), 316–322 (2007).
  • Belleville S. Cognitive training for persons with mild cognitive impairment. Int. Psychogeriatr.20(1), 57–66 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.